ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Diamedica Therapeutics (DMAC)

Technical Analysis Report for NASDAQ stock DMAC Diamedica Therapeutics. Dated: 18 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock DMAC Diamedica Therapeutics then click here. or read Experts views on Diamedica Therapeutics or Forecast & share price targets of Diamedica Therapeutics

Diamedica Therapeutics Opened at 6.05 and Closed at: 5.68, which is -6.69% of previous session's close. It moved within a range of 5.61 and 6.12
The session was a Bearish session with an average volume of 311200, which is 60.44% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

A Golden cross was found 3 days back on short term averages

Support for tomorrow is 5.39 and resistance for tomorrow is 5.9
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 5.49, 5.29 resistance for tomorrow's hourly charts is 6, 6.31

10 Day SMA for Diamedica Therapeutics (DMAC) is 6.3 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Diamedica Therapeutics (DMAC) is 6.25 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Diamedica Therapeutics (DMAC) is 6.59 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 7.41 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Diamedica Therapeutics is 7.15 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Diamedica Therapeutics is at 6.25 and 200 DMA is at 7.15, while 50 DMA and 100 DMA are at 6.59 and 7.41 respectively

Diamedica Therapeutics (DMAC) moving average of 20 SMA is at 6.25 and 20 EMA is at 6.29

Diamedica Therapeutics (DMAC) moving average of 50 SMA is at 6.59 and 50 EMA is at 6.65

Diamedica Therapeutics (DMAC) moving average of 100 SMA is at 7.41 and 100 EMA is at 6.94

Diamedica Therapeutics (DMAC) moving average of 200 SMA is at 7.15 and 200 EMA is at 6.85

Urogen Pharma has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Urogen Pharma, about 21.88% more returns!

Ovid Therapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 2.81% more returns!

Marker Therapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Marker Therapeutics, about 2.47% more returns!

Kura Oncology has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Kura Oncology, about 8.85% more returns!

Kala Pharmaceuticals has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Kala Pharmaceuticals, about 1417.77% more returns!

Adial Pharmaceuticals has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Adial Pharmaceuticals, about 14.76% more returns!

Aptorum Group has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Aptorum Group, about 7.77% more returns!

Arrowhead Pharmaceuticals has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 12.25% more returns!

Champions Oncology has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 13.21% more returns!

Diamedica Therapeutics has performed better than Cytosorbents Corporation in short term. Holding Diamedica Therapeutics could be a better choice for now!

Dexcom Inc has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Dexcom Inc, about 14.86% more returns!

Edap Tms has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Edap Tms, about 43.37% more returns!

Grifols S has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Grifols S, about 6.01% more returns!

Diamedica Therapeutics has performed better than Immutep in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics Technical analysis of indicators

Price action analysis of Diamedica Therapeutics (DMAC) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Diamedica Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Diamedica Therapeutics in short term and the sell signal is strong.

Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Diamedica Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 6.28 and Diamedica Therapeutics DMAC stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Diamedica Therapeutics DMAC stock. Volume based technical analysis of Diamedica Therapeutics DMAC stock is negative.

Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock DMAC Diamedica Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And DMAC Experts View which covers a lot of information including buying and selling signals

DMAC future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Diamedica Therapeutics or View Candle Stick Charts here

Chart Diamedica Therapeutics (DMAC)  Technical (Analysis) Reports Diamedica Therapeutics [

Videos related to: Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Diamedica Therapeutics (DMAC)  Technical (Analysis) Reports Diamedica Therapeutics [

 

Back to top